EucaLimus Post-Market Registry

RecruitingOBSERVATIONAL
Enrollment

251

Participants

Timeline

Start Date

March 14, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2028

Conditions
Coronary Arterioscleroses
Interventions
DEVICE

EucaLimus coronary stent system

The EucaLimus coronary stent system is a drug-coated coronary stent system, indicated for use in patients with symptomatic ischaemic coronary heart disease due to de novo lesions or restenosed lesions of the coronary arteries.

Trial Locations (8)

14004

RECRUITING

Hospital Universitario Reina Sofía, Córdoba

15006

RECRUITING

Motol University Hospital, Prague

27003

RECRUITING

Hospital Universitario Lucus Augusti, Lugo

38320

RECRUITING

Complejo Hospitalario Universitario de Canarias, San Cristóbal de La Laguna

46001

RECRUITING

Krajska nemocnice Liberec, Liberec

50400

RECRUITING

Institut Jantung Negara, Kuala Lumpur

08907

RECRUITING

Bellvitge University Hospital, L'Hospitalet de Llobregat

08026

RECRUITING

Hospital de la Santa Creu i Sant Pau, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Eucatech AG

INDUSTRY

collaborator

Centre Européen de Recherche Cardiovasculaire

UNKNOWN

lead

OrbusNeich

INDUSTRY

NCT06621524 - EucaLimus Post-Market Registry | Biotech Hunter | Biotech Hunter